Acetic Acid

Acetic Acid

SCHEMBL30239122

CC(=O)O.O=C1NCCCN1

nearest known ligand 0.37

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ADRA2AADRA2BADRA2CADRB2AGTR1AVPR1AAVPR1BAVPR2BDKRB2CALCRCHRNA3CHRNB4ESR1ESR2GHSRGNRHRGSC1HSPA8MALT1MC1RMC4RNOS1NOS2NOS3OPRK1OXTRRAMP1RAMP2RAMP3SCN5ASSTR1SSTR2SSTR3SSTR4SSTR5dacAdacBdacCfolPftsImrcAmrcBmrdArplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Acetic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
FFAR3 O14843 1/20 0.37
LCK P06239 1/20 0.37
FYN P06241 1/20 0.37
OR51E2 Q9H255 1/20 0.36
CRBN Q96SW2 3/20 0.35
FKBP5 Q13451 1/20 0.35
CCR2 P41597 1/20 0.32
L3MBTL1 Q9Y468 1/20 0.31
ALDH1A1 P00352 2/20 0.31
MAPT P10636 1/20 0.31
GFER P55789 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Acetic Acid SCHEMBL22528393 0.89 FFAR3 (0.41) FFAR3LCKFYNCRBNALDH1A1
SCHEMBL4725091 0.83 OR51E2 (0.47) OR51E2CRBNFKBP5
SCHEMBL88886 0.83
Acetone SCHEMBL10630317 0.80 CRBN (0.38) CRBNALDH1A1
SCHEMBL30957985 0.80
Bicarbonate SCHEMBL3127975 0.77 CRBN (0.39) OR51E2CRBN
SCHEMBL279773 0.76
2-Pyrrolidone SCHEMBL2155488 0.75 OR51E2 (0.71) FFAR3LCKFYNOR51E2CRBN
Methacrylic Acid SCHEMBL3205378 0.75 TDP1 (0.32) CRBNALDH1A1
Urea SCHEMBL10767914 0.75 CCR2 (0.31) OR51E2CCR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12509801-B2 Recycling of acid-superbase conjugate ionic liquids by water removal in the lyocell spinning process AALTO UNIVERSITY FOUNDATION SR (FI) 2025-12-30 US claimed
US-20230203717-A1 Recycling of acid-superbase conjugate ionic liquids by water removal in the lyocell spinning process AALTO UNIVERSITY FOUNDATION SR (FI) 2023-06-29 US claimed
CN-115917065-A Recovery of acid-superbase conjugated ionic liquids by water removal in lyocell fiber spinning processes 阿尔托大学基金会 2023-04-04 CN claimed
US-12509801-B2 Recycling of acid-superbase conjugate ionic liquids by water removal in the lyocell spinning process AALTO UNIVERSITY FOUNDATION SR (FI) 2025-12-30 US disclosed
US-20230203717-A1 Recycling of acid-superbase conjugate ionic liquids by water removal in the lyocell spinning process AALTO UNIVERSITY FOUNDATION SR (FI) 2023-06-29 US disclosed
CN-115917065-A Recovery of acid-superbase conjugated ionic liquids by water removal in lyocell fiber spinning processes 阿尔托大学基金会 2023-04-04 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12509801-B2 Recycling of acid-superbase conjugate ionic liquids by water removal in the lyocell spinning process SDC1, SDC2, CWC15 FFAR3 4144/4885LCK 3522/4885FYN 3150/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.